research
The cause of scleroderma is not known. It is hoped that research into the cause of scleroderma might lead to new advances in treatment and intervention. Scleroderma Australia aims to encourage and stimulate new ideas in the search for the cause and treatment of scleroderma through its research program which will be funded by member states, corporate and individual sponsors.
Current Studies
Here list the studies that are at present going on,
Future Research
Scleroderma Australia will begin funding research in 2009. Proposals will be received and reviewed by our Medical and Scientific Advisory Board (MSAB), who will then make recommendations for awarding research grants.
Medical and Scientific Advisory Board (MSAB)
Medical and Scientific Advisory Board members come from different states in Australia and reflect a range of therapeutic areas affected in scleroderma. Currently, MSAB members are:
- Eli Gabbay, Respiratory, WA
- Fiona Kermeen, Respiratory, Qld
- Eugene Kotlyar, Cardiology, NSW
- Susanna Proudman, Rheumatology, SA
- Janet Roddy, Rheumatology. WA
- Glenn Reeves, Immunology, NSW
- Les Schreiber, Rheumatology, NSW
- Wendy Stevens, Rheumatology, Vic
The first task of this newly appointed board is to create a research grant review process, which will include call for proposals, proposal review, funding allocation and reporting of results.